This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Alzheimer's Disease or Mild Cognitive Impairment
and you are
over 40
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

Based on prior published pilot studies, the investigators have initiated a larger, multi-site placebo-controlled clinical trial with Alzheimer's disease (AD) patients and individuals diagnosed with Mild Cognitive Impairment (MCI), with the hopes of (1) confirming (or denying) the above promising clinical findings, and (2) determining whether or not our formulation can delay MCI "conversion" to AD.

Provided treatments

  • : Nutriceutical formulation
  • Other: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01320527. The sponsor of the trial is University of Massachusetts, Worcester and it is looking for 135 volunteers for the current phase.
Official trial title:
A Phase II Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease